Last reviewed · How we verify
HP-5000 Topical Patch
At a glance
| Generic name | HP-5000 Topical Patch |
|---|---|
| Also known as | HP-5000 Patch |
| Sponsor | Noven Pharmaceuticals, Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A 12-week Study to Evaluate the Efficacy and Safety of HP-5000 in Subjects With Osteoarthritis Pain of the Knee (PHASE3)
- Irritation and Sensitization Study of HP-5000 Topical System (PHASE1)
- A 4-week Study to Evaluate the Efficacy and Safety of HP-5000 in Subjects With Knee Osteoarthritis (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- HP-5000 Topical Patch CI brief — competitive landscape report
- HP-5000 Topical Patch updates RSS · CI watch RSS
- Noven Pharmaceuticals, Inc. portfolio CI